Inventor · disambiguated record
Yoshiro Niitsu
Also filed as: NIITSU YOSHIRO
36 granted patents·28 pending applications·388 citations·filing 1986–2021
98Inventor score
Files withNITTO DENKO CORP43NIITSU YOSHIRO14CHUGAI PHARMACEUTICAL CO LTD1DAIICHI PURE CHEMICALS CO LTD1FUJINAGA KEI1
Top patents by PatentIndex Score
64 records- 0196US9393315B2Compounds for targeting drug delivery and enhancing siRNA activityNIITSU YOSHIRO·Filed 2012·Granted Jul 19, 2016·12 cites·17 claims
- 0296US9011903B2Cationic lipids for therapeutic agent delivery formulationsNIITSU YOSHIRO·Filed 2012·Granted Apr 21, 2015·26 cites·23 claims
- 0395US9963424B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2016·Granted May 8, 2018·8 cites·18 claims
- 0495US9771582B2RNA interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2015·Granted Sep 26, 2017·13 cites·35 claims
- 0595US9242001B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2014·Granted Jan 26, 2016·14 cites·29 claims
- 0695US8741867B2Retinoid-liposomes for treating fibrosisNIITSU YOSHIRO·Filed 2012·Granted Jun 3, 2014·34 cites·29 claims
- 0795US8664376B2Retinoid-liposomes for enhancing modulation of HSP47 expressionNIITSU YOSHIRO·Filed 2012·Granted Mar 4, 2014·30 cites·26 claims
- 0895US8173170B2Drug carrier and drug carrier kit for inhibiting fibrosisNIITSU YOSHIRO·Filed 2005·Granted May 8, 2012·32 cites·10 claims
- 0994US8178124B2Drug carrier and drug carrier kit for inhibiting fibrosisNIITSU YOSHIRO·Filed 2011·Granted May 15, 2012·20 cites·14 claims
- 1093US10196637B2Retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·7 cites·20 claims
- 1193US9206424B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2014·Granted Dec 8, 2015·21 cites·33 claims
- 1293US8686052B2Targeting agent for cancer cell or cancer-associated fibroblastNIITSU YOSHIRO·Filed 2008·Granted Apr 1, 2014·32 cites·5 claims
- 1393US8003621B2Drug carriersNITTO DENKO CORP·Filed 2008·Granted Aug 23, 2011·33 cites·26 claims
- 1492USRE48887ERNA interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2019·Granted Jan 11, 2022·2 cites·35 claims
- 1591US10100004B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Oct 16, 2018·4 cites·10 claims
- 1690US11084779B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2019·Granted Aug 10, 2021·2 cites·40 claims
- 1790US8710209B2Modulation of HSP47 expressionJIN XIAOMEI·Filed 2010·Granted Apr 29, 2014·22 cites·37 claims
- 1890US8652526B2Drug carrier and drug carrier kit for inhibiting fibrosisNIITSU YOSHIRO·Filed 2012·Granted Feb 18, 2014·10 cites·8 claims
- 1989US9456984B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2014·Granted Oct 4, 2016·10 cites·58 claims
- 2087US10000447B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Jun 19, 2018·2 cites·16 claims
- 2187US8574623B2Therapeutic agent for pulmonary fibrosisNITTO DENKO CORP·Filed 2012·Granted Nov 5, 2013·8 cites·6 claims
- 2286US10093923B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2015·Granted Oct 9, 2018·5 cites·35 claims
- 2385US10195145B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·4 cites·31 claims
- 2480US2022087531A1Rna interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2021·Application pending·0 cites
- 2579US9914983B2Apoptosis-inducing agentNITTO DENKO CORP·Filed 2013·Granted Mar 13, 2018·3 cites·2 claims
- 2674US9572886B2Agent for treating myelofibrosisNITTO DENKO CORP·Filed 2013·Granted Feb 21, 2017·1 cites·3 claims
- 2772US10669229B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2018·Granted Jun 2, 2020·0 cites·21 claims
- 2871US10532975B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2018·Granted Jan 14, 2020·0 cites·35 claims
- 2967US9976142B2Targeting molecule and a use thereofNITTO DENKO CORP·Filed 2015·Granted May 22, 2018·1 cites·2 claims
- 3066US6268336B1Pharmaceutical composition for treatment of hepatic diseasesCHUGAI PHARMACEUTICAL CO LTD·Filed 1997·Granted Jul 31, 2001·26 cites·6 claims
- 3164US2011104255A1Therapeutic agent for fibroid lungNITTO DENKO CORP·Filed 2009·Application pending·0 cites
- 3261US2011229558A1Agent for treating myelofibrosisNITTO DENKO CORP·Filed 2009·Application pending·0 cites
- 3357US2013216611A1Therapeutic agent for fibroid lungNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 3455US2014127187A1Targeting agent for cancer cell or cancer-associated fibroblastNITTO DENKO CORP·Filed 2014·Application pending·0 cites
- 3555US2012328694A1Therapeutic agent for fibroid lungNIITSU YOSHIRO·Filed 2012·Application pending·0 cites
- 3654US10098953B2Therapeutic agent for fibroid lungNITTO DENKO CORP·Filed 2015·Granted Oct 16, 2018·0 cites·6 claims
- 3752US2014212474A1Drug carriersNITTO DENKO CORP·Filed 2014·Application pending·0 cites
- 3852US2012269886A1Therapeutic agent for pulmonary fibrosisNIITSU YOSHIRO·Filed 2012·Application pending·0 cites
- 3951US10570396B2Cell death inducing agent for cells having BRAF gene mutation, growth suppressing agent for same cells and pharmaceutical composition for therapy of diseases caused by growth defect of same cellsNITTO DENKO CORP·Filed 2016·Granted Feb 25, 2020·0 cites·11 claims
- 4051US10093931B2Apoptosis inducerNITTO DENKO CORP·Filed 2015·Granted Oct 9, 2018·0 cites·2 claims
- 4150US2013011336A1Imaging agents of fibrotic diseasesNITTO DENKO CORP·Filed 2009·Application pending·0 cites
- 4250US2013210744A1Targeting agent for cancer cell or cancer-associated fibroblastNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 4350US2020370050A1Cell proliferation inhibitor and cancer treatment or prevention pharmaceutical composition including cell proliferation inhibitorNIITSU YOSHIRO·Filed 2018·Application pending·0 cites
- 4450US2013171240A1Drug carrier and drug carrier kit for inhibiting fibrosisNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 4549US2013045272A1Agent for treating myelofibrosisNITTO DENKO CORP·Filed 2012·Application pending·0 cites
- 4647US2013030034A9Modulation of timp1 and timp2 expressionQUARK PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4747US2016015656A2Composition for regenerating normal tissue from fibrotic tissueNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 4847US2019275158A1Skin fibrosis treatment agentNITTO DENKO CORP·Filed 2017·Application pending·0 cites
- 4945US2011257249A1Drug carriersNITTO DENKO CORP·Filed 2011·Application pending·0 cites
- 5044US2016281083A1Modulation of timp1 and timp2 expressionNITTO DENKO CORP·Filed 2015·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yoshiro Niitsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →